https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-05-11 / Cancer Immunol. Immunother. 2006 Mar;55(3):329-38
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-05-11 / Cancer Immunol. Immunother. 2006 Mar;55(3):329-382005-05-11 00:00:002005-05-11 00:00:00Chaperone-rich cell lysates, immune activation and tumor vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-04-28 / Cancer Immunol. Immunother. 2006 Mar;55(3):292-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-04-28 / Cancer Immunol. Immunother. 2006 Mar;55(3):292-82005-04-28 00:00:002019-02-15 08:48:23Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-04-04 / J. Leukoc. Biol. 2005 Aug;78(2):319-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-04-04 / J. Leukoc. Biol. 2005 Aug;78(2):319-242005-04-04 00:00:002019-02-15 08:44:47Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-04-01 / J. Neurooncol. 2005 Apr;72(2):107-13
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-04-01 / J. Neurooncol. 2005 Apr;72(2):107-132005-04-01 00:00:002019-02-15 08:46:57Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-03-11 / Am. J. Respir. Crit. Care Med. 2005 May;171(10):1168-77
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-03-11 / Am. J. Respir. Crit. Care Med. 2005 May;171(10):1168-772005-03-11 00:00:002019-02-15 08:50:35Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-03-01 / Lung Cancer 2005 Mar;47(3):337-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-03-01 / Lung Cancer 2005 Mar;47(3):337-502005-03-01 00:00:002019-02-15 08:45:37The large scale generation of dendritic cells for the immunization of patients with non-small cell lung cancer (NSCLC)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-02-01 / Scand. J. Immunol. 2005 Feb;61(2):147-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-02-01 / Scand. J. Immunol. 2005 Feb;61(2):147-562005-02-01 00:00:002019-02-15 08:50:24Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-01-01 / Curr. Pharm. Des. 2005;11(27):3475-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-01-01 / Curr. Pharm. Des. 2005;11(27):3475-832005-01-01 00:00:002019-02-15 08:50:23Immunotherapy and cancer vaccines in the management of breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-01-01 / Methods Mol. Med. 2005;109:127-36
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-01-01 / Methods Mol. Med. 2005;109:127-362005-01-01 00:00:002019-02-15 08:51:03Dendritic cells in clinical trials for multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-01-01 / Vopr Onkol 2005;51(6):685-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-01-01 / Vopr Onkol 2005;51(6):685-82005-01-01 00:00:002019-02-15 08:53:38[Combined radiotherapy and endovascular x-ray therapy for invasive cancer of the urinary bladder]
